Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
about
The B7 family of immune-regulatory ligandsIntracellular events and cell fate in filovirus infectionB7-H3: a costimulatory molecule for T cell activation and IFN-gamma productionB7-DC, a new dendritic cell molecule with potent costimulatory properties for T cellsAmbivalent role of the innate immune response in rabies virus pathogenesisPorcine PD-L1: cloning, characterization, and implications during xenotransplantationPD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell responseInvolvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activationSafety, activity, and immune correlates of anti-PD-1 antibody in cancerThe PD-1 pathway in tolerance and autoimmunityConstitutive and inducible expression of b7 family of ligands by human airway epithelial cellsActive systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMolecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphomaMolecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsB7x: a widely expressed B7 family member that inhibits T cell activationProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerInhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Melanoma immunotherapy dominates the fieldSubversion of the Immune Response by Rabies VirusContemporary Treatment of Metastatic Renal Cell CarcinomaProducer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsA Perspective of Immunotherapy for Prostate CancerImmune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?Inhibiting Immune Checkpoints for the Treatment of Bladder CancerClinical Development of the E75 Vaccine in Breast CancerExtracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic ToolsRole of the tumor microenvironment in mature B-cell lymphoid malignanciesProgrammed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control StudiesEmerging therapeutic targets in esophageal adenocarcinomaImmunotherapy for lung cancerMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursChimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and ProspectsGeneration of Tolerogenic Dendritic Cells and Their Therapeutic ApplicationsThe Role of γδ T Cells in Systemic Lupus ErythematosusImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumSignaling in T cells - is anything the m(a)TOR with the picture(s)?
P2860
Q21184159-49308D32-80D5-47A4-BFEF-A89BD582B941Q22305521-CFE7D2CA-8389-4530-B121-AF66559DA2BCQ24290870-2FAFEE4A-CBA8-4D47-B32F-C7832C461DF5Q24291070-984189DC-0B75-4ADF-B477-E81D4126EC74Q24300579-50E8B6A2-E997-4BA8-85DC-330B1FE056D7Q24305180-DCEA887F-792B-45A8-BC61-7A3450390F6AQ24339361-AC267B0A-3732-42D6-B57F-A2B77643C010Q24535835-C4D057AE-D8A8-4EF2-9D92-E315C3BB0E67Q24613354-843EB05C-CD01-494B-9A40-226D26867C71Q24633070-96EA4983-83B8-4CE0-9651-4DCB9638250CQ24633549-6C3A973B-51F1-42E8-A130-6333092367A9Q24645109-94A129C2-60C6-4C6D-B217-E3F7FA06E056Q24655393-05D859F2-850C-4601-866D-1F8D43D23691Q24670319-88121A08-521E-45BC-98BE-E6BCD260346EQ24672476-7FAD27CC-DC29-432D-B6CF-886F98E6DA02Q24673269-9B853618-432D-4C3A-BD4F-AD968BE96264Q24677367-0688DCD2-CF8B-4086-962B-7EA0E7C2731DQ24683252-F478DD66-4D06-4B55-91CD-4DB62B791DD4Q24685406-4EE597BA-7FAC-4431-A63D-B23146E56EE6Q24805693-95F5BC81-E7E6-4DFF-ABC6-37FAD454226BQ26738293-31693305-A326-4D0E-B513-D8858B3EDCD0Q26738671-DC53BC51-B712-43F3-B334-F4247D2543F0Q26739940-C5751FAD-4ADA-4298-BA41-05DE8936B60AQ26740594-9EC5F778-4BE7-44B4-9F5A-5A4CA04A632BQ26741260-09F44EAB-7603-48F3-92BA-DCFF869CA218Q26741277-D7537456-3428-497A-8E4F-5747E3C59589Q26742047-FA7E6416-53D5-47C8-B371-DAFBDA5F470DQ26744758-0093C738-E164-4B5A-B5D7-3D2EE6164ED5Q26745440-A7D6F503-A76F-45FA-BFA8-CCE2B5C1489BQ26747560-246FF7C1-B096-4B19-B41F-EABBC22639ACQ26748775-AB34BED2-F4FB-4037-A0DA-A2D3299EB660Q26749244-86CC2D6A-696E-4759-A448-B09E5A655F85Q26751209-D28D1E52-CE12-4AE5-96B6-2DCADD8A255BQ26751254-D43E3540-BD21-4C98-98BC-C510C17AAA4DQ26751659-D3CEC285-30DE-478E-973B-529CEBBD6314Q26753082-5F6938F4-810E-43B0-8FAA-D502BAC20204Q26764855-71522F8A-AEFC-47CD-91D7-AE0FA52E66A3Q26765027-CDBE6FFF-E56B-4943-BA8B-0C89A86495BBQ26765459-02CFCB3B-3854-4E2D-8CFC-B899FC835C72Q26767443-F9D9CBE7-9087-4388-8D27-6750FC5A4EC3
P2860
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@ast
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@en
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@nl
type
label
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@ast
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@en
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@nl
prefLabel
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@ast
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@en
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@nl
P2093
P2860
P3181
P356
P1476
Engagement of the PD-1 immunoi ...... ation of lymphocyte activation
@en
P2093
B M Carreno
G J Freeman
H F Horton
H Nishimura
P2860
P304
P3181
P356
10.1084/JEM.192.7.1027
P407
P577
2000-10-02T00:00:00Z